03:14 AM EDT, 03/25/2025 (MT Newswires) -- Eric Venker, President & Chief Operating Officer, on March 20, 2025, sold 750,000 shares in Roivant Sciences ( ROIV ) for $8,190,725. Following the Form 4 filing with the SEC, Venker has control over a total of 1,127,290 common shares of the company, with 1,127,290 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1635088/000114036125010120/xslF345X05/form4.xml